MoonLake Immunotherapeutics Shares Rise Following Q3 Financial Results

09:53 AM EST, 11/04/2026 (MT Newswires) -- MoonLake Immunotherapeutics (MLTX) shares were up 0.8% in early trading Wednesday after the company posted its Q3 financial results. The company reported a Q3 net loss of $0.93 per diluted share. Analysts polled by FactSet expected a loss of $0.75. As of Sept. 30, the company said it had $498.5 million in cash, cash equivalents and short-term marketable securities, expected to fund operations through mid-2028. Price: 11.79, Change: +0.09, Percent Change: +0.77